Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Longeveron Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Longeveron Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Jhaveri Nirav S. | Chief Financial Officer | 300,000 | Aug 25, 2026 | 1 |
| Lehr Paul T | General Counsel, Secretary | 861,423 | Aug 21, 2026 | 6 |
| Hajjar Roger Joseph | Director | 69,000 | Aug 21, 2026 | 1 |
| Soffer Rock | Director | 262,034 | Aug 21, 2026 | 1 |
| Paletta George A. Jr. | Director | 70,000 | Aug 21, 2026 | 2 |
| Cann Leah Rush | Director | 36,000 | Aug 21, 2026 | 1 |
| Ungaro Ursula | Director | 77,000 | Aug 21, 2026 | 1 |
| Desai Arjun JJ | Director | 36,000 | Aug 21, 2026 | 1 |
| Blass Devin | CTO & SVP of CMC | 711,735 | Aug 21, 2026 | 6 |
| Ascheim Deborah | Director | 36,000 | Aug 21, 2026 | 1 |
| Agafonova Nataliya | Chief Medical Officer | 716,914 | Aug 21, 2026 | 6 |
| Hare Joshua | Chief Scientific Officer | 1,607,796 | Aug 21, 2026 | 2 |
| Willard Stephen H | Chief Executive Officer | 771,681 | Jul 6, 2026 | 4 |
| Locklear Lisa | Chief Financial Officer | 443,181 | Jul 6, 2026 | 5 |
| Powell James Nathaniel | Chief Executive Officer | 125,593 | Jan 6, 2026 | 3 |
| Baluch Khoso | Director | 52,516 | Aug 13, 2025 | 0 |
| Kender Richard N | Director | 33,000 | Jul 17, 2025 | 0 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 420,904 | Jul 17, 2025 | 0 |
| Motwani Neha J. | Director | 33,000 | Jul 17, 2025 | 0 |
| Hare Neil E | Director | 29,352 | Aug 19, 2024 | 0 |
| Ross Cathy | Director | 10,000 | Jan 11, 2024 | 0 |
| Pfeffer Jeffrey | Director | 15,000 | Dec 29, 2023 | 0 |
| Losordo Douglas W | Director | – | Dec 26, 2023 | 0 |
| Clavijo James | CFO and Treasurer | 47,303 | Jun 29, 2023 | 0 |
| Borger Erin | Director | – | Dec 22, 2022 | 0 |
| Soffer Donald M | Director | 6,693,737 | Dec 22, 2022 | 0 |
| Girolamo Todd C | Director | 5,000 | Dec 22, 2022 | 0 |
| DS Med LLC | 10% Owner | 0 | May 19, 2022 | 0 |
| Min Kwan-Hong Christopher | Chief Medical Officer | 151,978 | Apr 12, 2022 | 0 |
| Green Geoff | CEO | 133,904 | Apr 8, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Locklear LisaChief Financial Officer | PPurchaseClass A Common Stock | +11.8K | – | – | +4.9%251.0K after | |
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Locklear LisaChief Financial Officer | PPurchaseClass A Common Stock | +29.4K | – | – | –29.4K after | Derivative |
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Baluch KhosoDirector | PPurchaseClass A Common Stock | +11.8K | – | – | +28.9%52.5K after | |
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Baluch KhosoDirector | PPurchaseClass A Common Stock | +29.4K | – | – | –29.4K after | Derivative |
| Jun 2, 2025 (view filing) | May 29-30 | 4 days | Soffer RockDirector | SSaleClass A Common Stock | −21.0K | $1.27 | −$26.8K | −9.1%209.0K after | 2 lots |
| May 27, 2025 (view filing) | May 22 | 5 days | Soffer RockDirector | SSaleClass A Common Stock | −2.00K | $1.32 | −$2.64K | −0.9%230.0K after | |
| May 16, 2025 (view filing) | May 16 | Same day | Hare JoshuaChief Scientific Officer | SSaleClass A Common Stock | −5.25K | $1.40 | −$7.35K | −0.7%721.8K after | |
| Dec 4, 2024 (view filing) | Dec 2 | 2 days | Baluch KhosoDirector | SSaleClass A Common Stock | −1.25K | $2.07 | −$2.59K | −5.0%23.8K after | |
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 10-11 | 2 days | Hare JoshuaChief Scientific Officer | PPurchaseClass A Common Stock | +148.9K | $2.35 | +$350.0K | +30.8%633.3K after | 2 lots |
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 10-11 | 2 days | Hare JoshuaChief Scientific Officer | PPurchaseClass A Common Stock | +148.9K | $0.125 | +$18.6K | –42.6K after | Derivative2 lots |
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 11 | 1 day | Hashad Mohamed Wa'el AhmedChief Executive Officer | PPurchaseClass A Common Stock | +10.6K | $2.35 | +$25.0K | +118.5%19.6K after | |
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 11 | 1 day | Hashad Mohamed Wa'el AhmedChief Executive Officer | PPurchaseClass A Common Stock | +10.6K | $0.125 | +$1.33K | –10.6K after | Derivative |
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 10-11 | 2 days | Soffer RockDirector | PPurchaseClass A Common Stock | +138.3K | $2.35 | +$325.0K | +196.9%208.5K after | 2 lots |
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 10-11 | 2 days | Soffer RockDirector | PPurchaseClass A Common Stock | +138.3K | $0.125 | +$17.3K | –31.9K after | Derivative2 lots |
| Jan 11, 2024 (view filing) | Jan 10 | 1 day | Ross CathyDirector | PPurchase | +5.00K | $1.31 | +$6.55K | +100.0%10.0K after | |
| Jan 2, 2024 (view filing) | Dec 28-29, 2023 | 5 days | Baluch KhosoDirector | PPurchase | +10.0K | $1.42 | +$14.2K | +200.0%15.0K after | 2 lots |
| Dec 29, 2023 (view filing) | Dec 28 | 1 day | Pfeffer JeffreyDirector | PPurchase | +10.0K | $1.35 | +$13.5K | +200.0%15.0K after | |
| Sep 13, 2023 (view filing)5:55 PM ET | Sep 12 | 1 day | Locklear LisaChief Financial Officer | PPurchase | +5.00K | $0.015 | +$75 | –5.00K after | Derivative |
| Sep 13, 2023 (view filing)5:00 PM ET | Sep 12 | 1 day | Hashad Mohamed Wa'el AhmedChief Executive Officer | SSale | −13.4K | $0.0164 | −$219.98 | –82.5K after | Derivative7 lots |
| Sep 13, 2023 (view filing)5:00 PM ET | Aug 25-Sep 8 | 19 daysLate | Hare JoshuaChief Scientific Officer | SSaleClass A Common Stock | −334.5K | $0.029 | −$9.70K | –39.2M after | Derivative6 lots |
| Jun 29, 2023 (view filing) | Jun 27-29 | 2 days | Clavijo JamesCFO and Treasurer | SSale | −23.5K | $3.47 | −$81.5K | −33.2%47.3K after | 3 lots |
| Jan 30, 2023 (view filing) | Jan 27 | 3 days | Hare JoshuaChief Scientific Officer | SSale | −20.0K | $4.28 | −$85.6K | −0.3%7.79M after | |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Hare JoshuaChief Scientific Officer | SSale | −20.0K | $3.74 | −$74.8K | −0.3%7.81M after | |
| Oct 18, 2022 (view filing) | Oct 12 | 6 daysLate | Hare JoshuaChief Scientific Officer | SSale | −100.0K | $3.61 | −$361.0K | −1.3%7.81M after | |
| Jun 7, 2022 (view filing) | Jun 3 | 4 days | Clavijo JamesCFO and Treasurer | SSale | −37.0K | $8.26 | −$305.2K | −31.7%79.6K after | |
| May 24, 2022 (view filing) | May 20-24 | 4 days | Soffer RockDirector | SSale | −19.5K | $7.83 | −$152.7K | −2.8%672.4K after | 3 lots |
| Apr 20, 2022 (view filing) | Apr 18-19 | 2 days | Hare JoshuaChief Scientific Officer | SSale | −20.0K | $10.00 | −$200.0K | −0.3%7.91M after | 2 lots |
| Oct 14, 2021 (view filing) | Oct 12 | 2 days | Hare JoshuaChief Scientific Officer | PPurchase | +2.50K | $3.69 | +$9.22K | 0.0%7.93M after | |
| Oct 14, 2021 (view filing) | Oct 13 | 1 day | Green GeoffCEO | PPurchase | +1.00K | $3.81 | +$3.81K | +0.7%139.7K after | |
| Oct 13, 2021 (view filing) | Oct 11-13 | 2 days | Soffer RockDirector | PPurchase | +19.9K | $3.66 | +$72.9K | +62.5%51.8K after | 3 lots |
| Oct 12, 2021 (view filing) | Oct 7 | 5 days | Clavijo JamesCFO and Treasurer | PPurchase | +5.00K | $3.34 | +$16.7K | +6.7%79.6K after | |
| Oct 12, 2021 (view filing) | Oct 7 | 5 days | Lehr Paul TGeneral Counsel, Secretary | PPurchase | +1.75K | $3.34 | +$5.84K | +1.5%116.4K after | |
| Oct 12, 2021 (view filing) | Oct 7-8 | 5 days | Hare JoshuaChief Scientific Officer | PPurchase | +5.00K | $3.39 | +$16.9K | +0.1%7.93M after | 2 lots |